Cagrilintide

Research Use OnlyNN9838CAS: 1415456-99-3ZP8396

A 37-amino acid long-acting acylated amylin analog that activates amylin and calcitonin receptors to modulate appetite signaling in homeostatic and hedonic brain regions, studied in clinical trials for weight management. Premium Research Peptide.

$69.99

Bundle & Save

Order within 14h 59m to ship today
Cutoff GMT+8 03:00 your time.
Fri, Aug 14 – Wed, Aug 19
Free shipment protection
Overnight shipping available
We accept
Free shipping on orders over $150
Damage protection
Secure checkout 256-bit SSL

Verified Test Results

Every batch, independently verified.

Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data released with this product.

ILSILS Laboratories

Certificate of Analysis

99%

Purity by HPLC

ISO 17025 Accredited8× Tested
ParameterResultSpecification
AppearanceGoodMeets spec
Purity99.84% · Pass≥ 95%
Net Peptide Content10.61mgReport
IdentityConfirmedMeets spec
Fentanyl ScreenNot DetectedPass
Heavy MetalsNot DetectedPass
SterilityNo GrowthPass
Endotoxin0.103 EU/mLReported

Representative report from lot CAG0002 (Cagrilintide). Your order ships with its own lot-specific certificate.

View this batch's certificate

Third-party verified

Certificate of Analysis

Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.

Cagrilintide 10mg

Latest

LOT CAG0002

99.84%

HPLC purity · meets spec

Labeled
10mg
Measured
10.61mg
Identity
Confirmed
Heavy metals
Not Detected
Sterility
No Growth
Endotoxin
0.103 EU/mL
Tested
Jul 30, 2026

8 assays passed · ISO/IEC 17025 accredited

View certificate

Cagrilintide 10mg

LOT CAG0001

99.04%

HPLC purity · meets spec

Labeled
10mg
Measured
10.42mg
Identity
Cagrilintide
Heavy metals
Not Detected
Sterility
No Growth
Endotoxin
< 0.05 EU/mL
Tested
May 29, 2026

7 assays passed · ISO/IEC 17025 accredited

View certificate

Compound Information

Technical specifications

Molecular Profile

What Is Cagrilintide?

TypeLong-acting acylated amylin analog
Amino acids37 (modified amylin sequence)
Molecular weight4,409 g/mol
CAS Number1415456-99-3
Molecular formulaC₁₉₄H₃₁₂N₅₄O₅₉S₂
ModificationC18 fatty diacid acylation
PubChem — CID 171397054
Storage Requirements

Stability Information

Store frozen or refrigeratedAvoid repeated freeze-thawProtect from light
Lyophilized (powder)
Store at -20°C long-term
Reconstituted
2-8°C
Light protection
Protect from light

Sources & References

Peer-reviewed research

New England Journal of Medicine

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity

2025DOI: 10.1056/NEJMoa2502081

Garvey WT, Blüher M, Osorto Contreras CK et al.

View Source
The Lancet

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

2021PMID: 34798060

Lau DCW et al.

View Source
The Lancet

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial

2021PMID: 33894838

Enebo LB et al.

View Source
Nature Communications

Structural and dynamic features of cagrilintide binding to calcitonin-family receptors

2025
View Source
Journal of Medicinal Chemistry

Development of Cagrilintide, a Long-Acting Amylin Analogue

2021
View Source
Cardiology in Review

Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity

2024DOI: 10.1097/CRD.0000000000000513PMID: 36883831

D'Ascanio AM, Mullally JA, Frishman WH

View Source
PMC

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3

2025
View Source
PubChem

Cagrilintide — CID 171397054

View Source
Novo Nordisk (Press Release)

CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial

2026
View Source
ClinicalTrials.gov

REDEFINE 1 — A Research Study to See How Well CagriSema Works in People Living With Overweight or Obesity

View Source

Important Research Notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

Frequently asked questions

How does my subscription work?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

How do I edit what's in my plan?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.

Can I change my next delivery date?

A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.

It's been a while since I took the quiz. Can I get a new recommendation?

Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.